558 related articles for article (PubMed ID: 15337790)
21. A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl.
Kimura T; Kaburaki H; Tsujino T; Ikeda Y; Kato H; Watanabe Y
FEBS Lett; 1998 May; 428(3):250-4. PubMed ID: 9654143
[TBL] [Abstract][Full Text] [Related]
22. Regulation of megakaryocytopoiesis by thrombopoietin and stromal cells.
Nagata Y; Nagahisa H; Nagasawa T; Todokoro K
Leukemia; 1997 Apr; 11 Suppl 3():435-8. PubMed ID: 9209416
[TBL] [Abstract][Full Text] [Related]
23. Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors.
Lannutti BJ; Drachman JG
Blood; 2004 May; 103(10):3736-43. PubMed ID: 14726379
[TBL] [Abstract][Full Text] [Related]
24. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
25. Signaling by the Mpl receptor involves IKK and NF-kappaB.
Zhang Y; Sun S; Wang Z; Thompson A; Kaluzhny Y; Zimmet J; Ravid K
J Cell Biochem; 2002; 85(3):523-35. PubMed ID: 11967992
[TBL] [Abstract][Full Text] [Related]
26. Thrombopoietin and its receptor.
Wendling F; Vainchenker W
Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
[TBL] [Abstract][Full Text] [Related]
27. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist.
Erickson-Miller CL; DeLorme E; Tian SS; Hopson CB; Stark K; Giampa L; Valoret EI; Duffy KJ; Luengo JL; Rosen J; Miller SG; Dillon SB; Lamb P
Exp Hematol; 2005 Jan; 33(1):85-93. PubMed ID: 15661401
[TBL] [Abstract][Full Text] [Related]
28. Phosphatidylinositol 3-kinase is necessary but not sufficient for thrombopoietin-induced proliferation in engineered Mpl-bearing cell lines as well as in primary megakaryocytic progenitors.
Geddis AE; Fox NE; Kaushansky K
J Biol Chem; 2001 Sep; 276(37):34473-9. PubMed ID: 11418622
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways.
Minamiguchi H; Kimura T; Urata Y; Miyazaki H; Bamba T; Abe T; Sonoda Y
Br J Haematol; 2001 Oct; 115(1):175-85. PubMed ID: 11722431
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.
Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y
Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823
[TBL] [Abstract][Full Text] [Related]
31. Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer.
Onishi M; Mui AL; Morikawa Y; Cho L; Kinoshita S; Nolan GP; Gorman DM; Miyajima A; Kitamura T
Blood; 1996 Aug; 88(4):1399-406. PubMed ID: 8695859
[TBL] [Abstract][Full Text] [Related]
32. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
[TBL] [Abstract][Full Text] [Related]
33. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.
Luoh SM; Stefanich E; Solar G; Steinmetz H; Lipari T; Pestina TI; Jackson CW; de Sauvage FJ
Mol Cell Biol; 2000 Jan; 20(2):507-15. PubMed ID: 10611229
[TBL] [Abstract][Full Text] [Related]
34. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.
Drachman JG; Kaushansky K
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2350-5. PubMed ID: 9122198
[TBL] [Abstract][Full Text] [Related]
35. Thrombopoietin-induced conformational change in p53 lies downstream of the p44/p42 mitogen activated protein kinase cascade in the human growth factor-dependent cell line M07e.
Ritchie A; Braun SE; He J; Broxmeyer HE
Oncogene; 1999 Feb; 18(7):1465-77. PubMed ID: 10050883
[TBL] [Abstract][Full Text] [Related]
36. Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities.
Inagaki K; Oda T; Naka Y; Shinkai H; Komatsu N; Iwamura H
Blood; 2004 Jul; 104(1):58-64. PubMed ID: 15001470
[TBL] [Abstract][Full Text] [Related]
37. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.
Bacon CM; Tortolani PJ; Shimosaka A; Rees RC; Longo DL; O'Shea JJ
FEBS Lett; 1995 Aug; 370(1-2):63-8. PubMed ID: 7544303
[TBL] [Abstract][Full Text] [Related]
38. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
39. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways.
Kirito K; Watanabe T; Sawada K; Endo H; Ozawa K; Komatsu N
J Biol Chem; 2002 Mar; 277(10):8329-37. PubMed ID: 11756417
[TBL] [Abstract][Full Text] [Related]
40. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.
Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F
Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
